A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants
Condition:   Non-alcoholic Steatohepatitis Interventions:   Drug: Cotadutide;   Drug: Cotadutide-placebo;   Drug: Moxifloxacin;   Drug: Moxifloxacin-placebo Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2022 Category: Research Source Type: clinical trials